
Please try another search
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, research and development, production, sales and medical services in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. Its project under research covers major disease areas such as anti-tumor, liver disease, and cerebrovascular drugs. The company was founded in 2003 and is based in Shannan, China.
Name | Age | Since | Title |
---|---|---|---|
Ling Ping Tao | 52 | - | GM & Chairman of the Board |
Xiao Gang Tao | 49 | 2015 | Deputy GM & Director |
Zi Qiang Pan | 60 | 2019 | Independent Director |
Chao He | 66 | 2019 | Independent Director |
Qian He | 53 | 2022 | Independent Director |
Hui Zhang | 70 | 2022 | Director |
Yan Chen | 47 | 2017 | Chairman of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review